Genevoyager owns the self-developed insect baculovirus One-Bac 4.0 system independent patent group. One-Bac 4.0 system through introduction of new strategy of AAV expression element regulation, combined with key process optimization, achieves high yield, high activity, solid rate, and single batch capacity up to 1E+18vg in the process of large-scale production of AAV using insect system.